Secondary analysis of DanGer Shock (345 patients, STEMI with cardiogenic shock): 180-day mortality rose with symptom-to-randomisation delay (36% to 62%); late patients were older. Pump vs standard care OR 0.51 in first three quartiles vs 0.92 in the last (interaction P=0.26).
Secondary analysisn = 345
Jensen et al. Delay From First Symptoms in Patients Presenting With STEMI and Cardiogenic Shock: Insights From the DanGer Shock Trial